Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person During the initiation phase of coagulation, factor IX (FIX) ...

Class:IdSummation:9929073
_displayNameDuring the initiation phase of coagulation, factor IX (FIX) ...
_timestamp2025-02-18 10:15:44
created[InstanceEdit:9929074] Shamovsky, Veronica, 2024-11-20
literatureReference[LiteratureReference:9671038] Structural biology of factor VIIa/tissue factor initiated coagulation
[LiteratureReference:9671236] Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation
[LiteratureReference:9671237] The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor
[LiteratureReference:9671235] A sequential mechanism for exosite-mediated factor IX activation by factor XIa
[LiteratureReference:9671045] High resolution structures of p-aminobenzamidine- and benzamidine-VIIa/soluble tissue factor: unpredicted conformation of the 192-193 peptide bond and mapping of Ca2+, Mg2+, Na+, and Zn2+ sites in factor VIIa
[LiteratureReference:140887] Nucleotide sequence of the gene for human factor IX (antihemophilic factor B)
[LiteratureReference:140753] The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor
[LiteratureReference:9929066] A candidate activation pathway for coagulation factor VII
[LiteratureReference:9670704] Activation of human factor IX (Christmas factor)
[LiteratureReference:9929056] Formation of factors IXa and Xa by the extrinsic pathway: differential regulation by tissue factor pathway inhibitor and antithrombin III
[LiteratureReference:140741] Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor
[LiteratureReference:9929050] Role of the Gla and first epidermal growth factor-like domains of factor X in the prothrombinase and tissue factor-factor VIIa complexes
[LiteratureReference:9929057] The first epidermal growth factor-like domains of factor Xa and factor IXa are important for the activation of the factor VII--tissue factor complex
[LiteratureReference:9929076] Crystal structure of the calcium-stabilized human factor IX Gla domain bound to a conformation-specific anti-factor IX antibody
[LiteratureReference:9929048] The tissue factor region that interacts with substrates factor IX and Factor X
[LiteratureReference:9934591] Membrane binding properties of the factor IX gamma-carboxyglutamic acid-rich domain prepared by chemical synthesis
modified[InstanceEdit:9929753] Shamovsky, Veronica, 2024-11-28
[InstanceEdit:9934807] Shamovsky, Veronica, 2025-01-10
[InstanceEdit:9938569] Shamovsky, Veronica, 2025-02-18
textDuring the initiation phase of coagulation, factor IX (FIX) interacts with tissue factor (TF)-bound factor VIIa (FVIIa) forming the ternary TF:FVIIa:FIX complex where FIX is converted to FIXa (Osterud B & Rapaport SI 1977; Komiyama Y et al., 1990; Kirchhofer D et al., 2000; Zhong D et al. 2002). The conversion of FIX to FIXa requires proteolytic cleavages after Arg191 and Arg226. Upon this cleavage, the activation peptide (Ala192-Arg226) is released leaving the light chain, FIX (47-191), and the heavy chain, FIX (227-461), that are held together by a disulfide bond to form the activated factor IX (FIXa) (Di Scipio RG et al., 1978; Yoshitake S et al. 1985; Geng Y et al., 2012; reviewed by Vadivel K & Bajaj SP 2012). This cleavage is catalyzed by the protease activity of FVIIa in the presence of TF and phosphatidylserine-rich phospholipid in the Ca2+-dependent manner (Osterud B & Rapaport SI 1977; Komiyama Y et al., 1990; Banner DW et al. 1996; Lu G et al., 2004; Bajaj SP et al. 2006). The light chain of FIX contains the gamma-carboxyglutamic acid (Gla) domain, and two epidermal growth factor-like (EGF1 and EGF2) domains. The heavy FIX (227-461) chain contains the catalytic protease domain (Yoshitake S et al. 1985). Gla and EGF1 domains of FIX are responsible for the interaction with FVIIa and TF, facilitating the formation of the ternary complex (Zhong D et al. 2002; Thiec F et al., 2003; Ndonwi M et al., 2005; reviewed by Vadivel K & Bajaj SP 2012). Additionally, FIX binds to phospholipid membranes through the Gla domain (Jacobs M et al. 1994; Huang M et al., 2004). Further, computational models of TF:FVIIa:FIX or TF:FVIIa:FX suggest that in the formed ternary complex, the scissile peptide bond in FIX (and in the structurally similar FX) moves toward the active site cleft in FVIIa, triggering the formation of the oxyanion hole in FVIIa to enable efficient proteolysis (Vadivel K & Bajaj SP 2012). FVIIa, bound to TF at the endothelial cell surface, cleaves FIX first after Arg191, forming the inactive intermediate which is released from FVIIa. The intermediate form of FIX must rebind to the protease to be cleaved after Arg226 to form an activated FIXa. As the second cleavage is rate-limiting, the inactive intermediate accumulates during FIX activation by FVIIa (reviewed by Vadivel K & Bajaj SP 2012).
(summation)[Reaction:9929051] TF:FVIIa+FIX -> TF:FVIIa:FIXa + FIX activation peptide (TF:F7a catalyst) [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by During the initiation phase of coagulation, factor IX (FIX) ... (9929073)